CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease-Reference-Cited by-同舟云学术

CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease

Published:2021-12-16 Issue:51 Volume:6 Page:35780-35798
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Gupta Rohan¹,Kumar Pravir¹^ORCID

Affiliation:

1. Molecular Neuroscience and Functional Genomics Laboratory, Department of Biotechnology, Delhi Technological University (Formerly DCE), Delhi 110042, India

Funder

Delhi Technological University

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.1c05827

Reference137 articles.

1. Alzheimer's Disease and Parkinson's Disease

2. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue

3. Blood-derived amyloid-β protein induces Alzheimer’s disease pathologies

4. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review and analysis of key biomarkers in Alzheimer’s disease;Frontiers in Neuroscience;2024-02-20

2. Identification of key lipid metabolism-related genes in Alzheimer’s disease;Lipids in Health and Disease;2023-09-22

3. Proteomic Analysis of Protective Effects of Dl-3-n-Butylphthalide against mpp + -Induced Toxicity via downregulating P53 pathway in N2A Cells;Proteome Science;2023-01-03

4. Neobaicalein prevents isoflurane anesthesia-induced cognitive impairment in neonatal mice via regulating CREB1;Clinics;2023-01